Maspin Modulates Prostate Cancer Cell Apoptotic and Angiogenic Response to Hypoxia Via Targeting AKT

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2008 Oct 22

PMID 18931702

Citations 15

Authors

S McKenzie

S Sakamoto

N Kyprianou

Affiliations

Soon will be listed here.

Abstract

Hypoxia has been previously linked to the development of both benign prostatic hyperplasia and prostate cancer. This study investigated the effect of maspin, an extracellular matrix (ECM) tumor suppressor, on the apoptotic response of prostate cancer cells to hypoxia. Gene expression profiling of human benign and malignant prostate epithelial cells after exposure to hypoxia or normoxia revealed dramatic changes in ECM regulators. Maspin was found to be overexpressed in response to hypoxia in prostate cancer cells, but not in benign prostate cells. To dissect the contribution of maspin to tumor cell responses within a hypoxic microenvironment, we used maspin-overexpressing DU-145 human prostate cancer cells. Exposure to hypoxic conditions (1% O(2)) led to a significant increase in apoptosis in the DU-145 maspin cells, compared to DU-145 neo-transfectants without a significant effect on cell migration. This enhanced sensitivity to hypoxia-induced apoptosis leads to a significant suppression of tumor growth and tumor vascularity in vivo by targeting Akt and focal adhesion kinase activation. Our findings implicate maspin in prostate cancer cell response to hypoxia via recruitment of intracellular signaling partners. This study may have significance in the identification of maspin-driven therapeutic targeting in advanced metastatic prostate cancer.

Citing Articles

Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets.

Liu Y, Li X, Yang J, Chen S, Zhu C, Shi Y Heliyon. 2024; 10(8):e29655.

PMID: 38655365 PMC: 11036058. DOI: 10.1016/j.heliyon.2024.e29655.

Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects.

Tang S, Ling Z, Jiang J, Gu X, Leng Y, Wei C Front Oncol. 2022; 12:1037794.

PMID: 36523976 PMC: 9745138. DOI: 10.3389/fonc.2022.1037794.

Biologically Targeted Radiation Therapy: Incorporating Patient-Specific Hypoxia Data Derived from Quantitative Magnetic Resonance Imaging.

Her E, Haworth A, Sun Y, Williams S, Reynolds H, Kennedy A Cancers (Basel). 2021; 13(19).

PMID: 34638382 PMC: 8507789. DOI: 10.3390/cancers13194897.

Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway.

Wang N, Chang L Hum Cell. 2020; 33(3):663-675.

PMID: 32409959 DOI: 10.1007/s13577-020-00345-7.

Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.

Lin Y, Tsui K, Chang K, Hou C, Feng T, Juang H Cancers (Basel). 2019; 12(1).

PMID: 31861435 PMC: 7016534. DOI: 10.3390/cancers12010010.

References

Zhang M, Volpert O, Shi Y, BOUCK N . Maspin is an angiogenesis inhibitor. Nat Med. 2000; 6(2):196-9. DOI: 10.1038/72303. View

Lee B, Kim W, Jung J, Cho S, Park J, Kim J . A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis. 2007; 29(1):44-51. DOI: 10.1093/carcin/bgm232. View

Kyprianou N, Bruckheimer E, Guo Y . Cell proliferation and apoptosis in prostate cancer: significance in disease progression and therapy. Histol Histopathol. 2000; 15(4):1211-23. DOI: 10.14670/HH-15.1211. View

Blacque O, Worrall D . Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem. 2002; 277(13):10783-8. DOI: 10.1074/jbc.M110992200. View

Semenza G . HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002; 8(4 Suppl):S62-7. DOI: 10.1016/s1471-4914(02)02317-1. View

Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S . Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene. 2002; 21(26):4089-98. DOI: 10.1038/sj.onc.1205507. View

Abraham S, Zhang W, Greenberg N, Zhang M . Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol. 2003; 169(3):1157-61. DOI: 10.1097/01.ju.0000040245.70349.37. View

Ferrara N, Gerber H, LeCouter J . The biology of VEGF and its receptors. Nat Med. 2003; 9(6):669-76. DOI: 10.1038/nm0603-669. View

Cher M, Biliran Jr H, Bhagat S, Meng Y, Che M, Lockett J . Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci U S A. 2003; 100(13):7847-52. PMC: 164676. DOI: 10.1073/pnas.1331360100. View

10.

Ngamkitidechakul C, Warejcka D, Burke J, OBrien W, Twining S . Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J Biol Chem. 2003; 278(34):31796-806. DOI: 10.1074/jbc.M302408200. View

11.

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

12.

Schaefer J, Zhang M . Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med. 2003; 3(7):653-8. DOI: 10.2174/1566524033479519. View

13.

Welsh S, Powis G . Hypoxia inducible factor as a cancer drug target. Curr Cancer Drug Targets. 2003; 3(6):391-405. DOI: 10.2174/1568009033481732. View

14.

Gao N, Shen L, Zhang Z, Leonard S, He H, Zhang X . Arsenite induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol Cell Biochem. 2004; 255(1-2):33-45. DOI: 10.1023/b:mcbi.0000007259.65742.16. View

15.

Liu J, Yin S, Reddy N, Spencer C, Sheng S . Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res. 2004; 64(5):1703-11. DOI: 10.1158/0008-5472.can-03-2568. View

16.

Debes J, Tindall D . Mechanisms of androgen-refractory prostate cancer. N Engl J Med. 2004; 351(15):1488-90. DOI: 10.1056/NEJMp048178. View

17.

Zou Z, Anisowicz A, Hendrix M, Thor A, Neveu M, Sheng S . Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994; 263(5146):526-9. DOI: 10.1126/science.8290962. View

18.

Sheng S, Carey J, Seftor E, Dias L, Hendrix M, Sager R . Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A. 1996; 93(21):11669-74. PMC: 38116. DOI: 10.1073/pnas.93.21.11669. View

19.

Shi Y, Wang Y, Bingle L, Gong L, Heng W, Li Y . In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J Pathol. 2005; 205(4):530-6. DOI: 10.1002/path.1734. View

20.

Rofstad E, Mathiesen B, Henriksen K, Kindem K, Galappathi K . The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res. 2005; 65(6):2387-96. DOI: 10.1158/0008-5472.CAN-04-3039. View